Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma

Leukemia and Lymphoma

Volumn 46, Issue 10, 2005, Pages 1441-1448

  Fenske, Timothy S ^a   Kahl, Brad S ^a   Eickhoff, Jens ^b   Mitchell, Teri L ^a   Smith, Eileen P ^a   Atkinson, Elizabeth ^a   McCoy, Alice Garry ^a   Eckstein, Linda ^a   Flynn, Bridget ^a   McMannes, Jan ^a   Howard, Steven ^b   Longo, Water L ^a  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Autologous stem cell transplantation; Follicular lymphoma; Mantle cell lymphoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; NARCOTIC AGENT; PREDNISONE; SEDATIVE AGENT; THIOTEPA; VINCRISTINE;

ABDOMINAL PAIN; ACIDOSIS; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALKALOSIS; ANOREXIA; ARTHRITIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLEEDING; BLOOD TOXICITY; CANCER SURVIVAL; CARDIOTOXICITY; COHORT ANALYSIS; COLITIS; CONFUSION; CONTROLLED STUDY; DELIRIUM; DERMATITIS; DIARRHEA; DISEASE SEVERITY; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; EDEMA; ELECTROLYTE DISTURBANCE; FEBRILE NEUTROPENIA; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GOUT; GRAFT REJECTION; HEART ARRHYTHMIA; HEMODIALYSIS; HEPATORENAL SYNDROME; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERKALEMIA; HYPERNATREMIA; HYPOCALCEMIA; HYPOGONADISM; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; HYPOTHYROIDISM; HYPOXIA; ILEUS; INFECTION; KIDNEY FAILURE; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TOXICITY; LONG TERM CARE; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MENTAL DISEASE; MUCORMYCOSIS; MUCOSA INFLAMMATION; MULTIPLE ORGAN FAILURE; MYELODYSPLASIA; NAUSEA; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL; SECOND CANCER; SEPTIC SHOCK; SKIN NECROSIS; SKIN TOXICITY; SKIN ULCER; STOMATITIS; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE; THRUSH; VEIN OCCLUSION; VOMITING; WHOLE BODY RADIATION;

ADULT; AGED; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; SURVIVAL RATE; THIOTEPA; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 26944490733     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500144656     Document Type: Article

References (32)

1. Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. Eur J Haematol 2000;65:17-22.
2. Brice P, Simon D, Bouabdallah R, Belanger C, Haioun C, Thieblemont C, et al. High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol. Ann Oncol 2000;11:1585-1590.
3. Apostolidis J, Gupta RK, Grenzelias D, Johnson PW, Pappa VI, Summers KE, et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. J Clin Oncol 2000;18:527-536.
4. Rohatiner AZ, Johnson PW, Price CG, Arnott SJ, Amess JA, Norton AJ, et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994;12:1177-1184.
5. Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnson HE, et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol 2003;21:3918-3927.
6. Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fischer DC, et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood 1999;94:3325-3333.
7. Horning SJ, Negrin RS, Hoppe RT, Rossenberg SA, Chao NJ, Long GD, et al. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Blood 2001;97:404-409.
8. Corradini P, Ladetto M, Zallio F, Astolfi M, Rizzo E, Sametti S, et al. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes. J Clin Oncol 2004;22:1460-1468.
9. Hunault-Berger M, Ifrah N, Solal-Celigny P. Intensive therapies in follicular non-Hodgkin lymphomas. Blood 2002;100:1141-1152.
10. Bierman PJ, Vose JM, Anderson JR, Bishop MR, Kessinger A, Armitage JO. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997;15:445-450.
11. McCoy GA, Smith EP, Atkinson AM, Baranski B, Kahl BS, Juckett M, et al. A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: Long term experience with etoposide and thiotepa. Bone Marrow Transplantation 2004;33:19-24.
12. Herzig RH, Fay JW, Herzig GP, editors. Phase I-II studies with high-dose thiotepa and autologous marrow transplantation in patients with refractory malignancies. New York: Wiley and Sons; 1987. pp 17-23.
13. Lazarus HM, Reed MD, Spitzer TR, Rabaa MS, Blumer JL. High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer. Cancer Treat Rep 1987;71:689-695.
14. Jacobs P, King HS, Dent DM, Hayes M. VP-16-213 in the treatment of stage III and IV diffuse large cell lymphoma. Cancer 1985;56:1006-1013.
15. Cervantes F, Reverter JC, Montserrat E, Rozman C. Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustine. Cancer Treat Rep 1986; 70:665-667.
16. Wolff SN, Fer MF, McKay CM, Hande KR, Hainsworth JD, Greco FA. High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: A phase I study. J Clin Oncol 1983;1:701-705.
17. Giannone L, Wolff SN. Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation. Cancer Treat Rep 1987;71:759-761.
18. Finlay JL, August C, Packer R, Zimmerman R, Sutton L, Freid A, et al. High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. J Neurooncol 1990;9:239-248.
19. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fischer RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244-1253.
20. Schiller JH, Ritch PS, Storer B, Trump DL. A pilot study of short-course, high-dose cytosine arabinoside, etoposide, and cisplatin in refractory, aggressive-histology, non-Hodgkin's lymphomas. Am J Clin Oncol 1989;12:502-506.
21. Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LN. High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: A dose-finding pilot study. J Clin Oncol 1995;13:2916-2923.
22. Hui SK, Das RK, Thomadsen B, Henderson D. CT-based analysis of dose homogeneity in total body irradiation using lateral beam. J Appl Clin Med Phys 2004;5:71-79.
23. Deconinck E, Foussard C, Milpied N, Betrand P, Michenet P, Cournillet-LeFebvre P, et al. High dose therapy followed by autologous purged stem cell transplantation and doxorubicin based chemotherapy in patients with advanced follicular lymphoma: A randomized multicenter study by the GOE-LAMS. Blood 2005.
24. Lenz G, Dreyling M, Schiegnitz E, Forstpointneer R, Wandt H, Freund M, et al. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: Results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Blood 2004;104:2667-2674.
25. Sebban S, Belanger C, Brousse N, Mounier N, Brice P, Haioun C, et al. Comparison of CHVP + Interferon with CHOP followed by autologous stem cell transplantation with a TBI conditioning regimen in untreated patients with high tumor burden follicular lymphoma: results of the randomized GELF94 trial (G.E.L.A. Study Group). Blood 2003; 102:104a. Abstract 354.
26. Horning SJ. Follicular lymphoma: Have we made any progress? Ann Oncol 2000;11 (Suppl 1):23-27.
27. Van Besien K, Loberiza FR, Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood 2003;102:3521-3529.
28. Emmanouilides C, Asuncion DJ, Wolf C, Scott S, Territo M. Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplant 2003;32:863-867.
29. Friedberg JW, Neuberg D, Monson E, Jallow H, Nadler LM, Freedman AS. The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 2001;7:446-453.
30. Press OW, Eary JF, Gooley T, Gopak AK, Liu S, Rojendran JG, et al. A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood 2000;96:2934-2942.
31. Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Woo BL, et al. High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma. Blood 2002;99:3158-3162.
32. Gopal AK, Gooley TA, Maloney DG, Petersdorf SH, Sary JF, Rajendran JG, et al. High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: A multivariable cohort analysis. Blood 2003; 102:2351-2357.